Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging
US-10753941-B2 · Aug 25, 2020 · US
US11220629B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11220629-B2 |
| Application number | US-201916961569-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 11, 2019 |
| Priority date | Jan 11, 2018 |
| Publication date | Jan 11, 2022 |
| Grant date | Jan 11, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Fluorescent compounds that have aggregation-induced emission (AIE) characteristics. The compounds can be utilized as lipid droplet (LD)-specific bio-probes in cell imaging, with high photostability and brightness. For example, the compounds can be used for specific two-photon LDs staining in live cells and deep-tissues at ultralow concentrations. The compounds exhibit a large Stokes shift (>110 nm), high solid fluorescence quantum yields (up to 0.30), a good two-photon absorption cross-section (45-100 GM at 860 nm), high biocompatibility, and good photostability.
Opening claim text (preview).
We claim: 1. A fluorescent compound exhibiting aggregation induced emission properties, the compound having the following backbone structural formula: wherein R 1 , R 2 , and R 3 are independently selected from the group consisting of C n H 2n+1 , C 6 H 5 , C 10 H 7 , C n H 2n COOH, C n H 2n NCS, C n H 2n N 3 , C n H 2n NH 2 , C n H 2n Cl, C n H 2n Br, C n H 2n I and wherein R′ is selected from the group consisting of C n H 2n NCS, C n H 2n N 3 , C n H 2n NH 2 , C n H 2n Cl, C n H 2n Br, C n H 2n I, and wherein R 4 , R 5 , and R 6 are independently selected from the group consisting of H, CH 3 , F, Cl, Br, I, CN, CF 3 , NO 2 , Ph, Py, CH═CHPh, and C≡CPh; and wherein n is an integer ranging from 1 to 10. 2. The compound according to claim 1 , wherein the compound comprises one or more compounds selected from the group consisting of: 3. A method of cellular imaging, comprising: contacting a target cell with the compound of claim 1 ; and identifying a target of interest in the target cell using an imaging method. 4. The method of claim 3 , wherein the target of interest comprises lipid droplets. 5. The method of claim 3 , wherein the imaging method is selected from the group consisting of fluorescence microscopy and confocal laser scanning microscopy. 6. The method of claim 5 , wherein the fluorescence microscopy comprises two-photon fluorescence imaging. 7. The method of claim 3 , wherein the target cell is a live cell. 8. The method of claim 7 , wherein the target cell is in live tissue. 9. The method of claim 3 , wherein a concentration of the compound is 50 nM or less. 10. A fluorescent compound exhibiting aggregation induced emission properties, the compound comprising one or more compounds selected from the group consisting of: 11. A method of cellular imaging, comprising: contacting a target cell with the compound of claim 10 ; and identifying a target of interest in the target cell using an imaging method. 12. The method of claim 11 , wherein the target of interest comprises lipid droplets. 13. The method of claim 11 , wherein the imaging method is selected from the group consisting of fluorescence microscopy and confocal laser scanning microscopy. 14. The method of claim 11 , wherein the fluorescence microscopy comprises two-photon fluorescence imaging. 15. The method of claim 11 , wherein the target cell is a live cell. 16. The method of claim 15 , wherein the target cell is in live tissue. 17. The method of claim 11 , wherein a concentration of the compound is 50 nM or less. 18. A method of cellular imaging, comprising: contacting a target cell with a compound having the following backbone structural formula wherein R 1 , R 2 , and R 3 are independently selected from the group consisting of C n H 2n+1 , C 6 H 5 , C 10 H 7 , C n H 2n COOH, C n H 2n NCS, C n H 2n N 3 , C n H 2n NH 2 , C n H 2n Cl, C n H 2n Br, C n H 2n I and wherein R′ is selected from the group consisting of C n H 2n NCS, C n H 2n N 3 , C n H 2n NH 2 , C n H 2n Cl, C n H 2n Br, C n H 2n I, and wherein R 4 , R 5 , and R 6 are independently selected from the group consisting of H, CH 3 , F, Cl, Br, I, CN, CF 3 , NO 2 , Ph, Py, CH═CHPh, and C≡CPh; and wherein n is an integer ranging from 1 to 10; and identifying a target of interest in the target cell using an imaging method. 19. The method according to claim 18 , wherein the compound comprises one or more compounds selected from the group consisting of: 20. The method according to claim 18 , wherein the target of interest comprises lipid droplets.
containing organic luminescent materials · CPC title
Nitriles · CPC title
Non-condensed systems · CPC title
Condensed systems · CPC title
arrangements using fluorescence or luminescence · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.